Display options
Share it on

Dig Dis Sci. 1993 May;38(5):888-95. doi: 10.1007/BF01295916.

Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.

Digestive diseases and sciences

J Y Lau, G L Bird, N V Naoumov, R Williams

Affiliations

  1. Department of Medicine, University of Florida, Gainesville 32610.

PMID: 7683263 DOI: 10.1007/BF01295916

Abstract

To determine the relationship between hepatitis B virus (HBV) replication and HLA antigen display at a cellular level, the hepatic expression of HLA antigens and HBV genome (HBV-DNA)/gene products (HBsAg/HBcAg) was studied in 24 patients with chronic HBV infection using simultaneously immunohistochemistry and nonisotopic in situ hybridization. The effect of interferon-alpha and interferon-gamma on hepatocyte HLA antigen expression was also evaluated using primary hepatocyte culture in eight patients with chronic HBV infection. HLA class I antigens were detected on hepatocyte membrane in 23 patients (95.8%). Hepatocytes positive for HBcAg and HBV-DNA (cytoplasmic +/- nuclear) were either negative or only faintly positive for HLA class I antigens, while hepatocytes positive for HBsAg showed similar levels of HLA class I antigen expression compared with those hepatocytes with no HBsAg expression. In contrast, hepatocytes adjacent to inflammatory infiltrates, whether positive for HBV-DNA or HBV antigens or not, were always strongly positive for HLA class I antigens. Furthermore, active liver histology (N = 12) was associated with a higher overall level of hepatic HLA class I antigen expression as compared with inactive histology (N = 12, P = 0.003). Both interferon-alpha and interferon-gamma treatment in vitro enhanced hepatocyte HLA class I antigen expression. These data indicate that expression of HLA class I antigens is not enhanced on the membrane of hepatocytes with HBV replication, and this may be one factor that permits the development of viral persistence.

References

  1. Transplantation. 1986 Aug;42(2):109-17 - PubMed
  2. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2888-92 - PubMed
  3. J Immunol. 1985 Nov;135(5):2923-8 - PubMed
  4. J Clin Pathol. 1991 Feb;44(2):107-14 - PubMed
  5. Hepatology. 1986 Sep-Oct;6(5):957-61 - PubMed
  6. J Hepatol. 1991 Mar;12(2):195-202 - PubMed
  7. Hepatology. 1986 May-Jun;6(3):349-53 - PubMed
  8. J Immunol. 1985 Nov;135(5):2914-22 - PubMed
  9. Eur J Immunol. 1984 Jan;14(1):52-6 - PubMed
  10. Hepatology. 1982 Nov-Dec;2(6):789-90 - PubMed
  11. J Virol. 1990 Aug;64(8):4025-8 - PubMed
  12. Hepatology. 1991 Sep;14(3):416-21 - PubMed
  13. Hepatology. 1986 Sep-Oct;6(5):981-9 - PubMed
  14. J Clin Pathol. 1991 Nov;44(11):905-8 - PubMed
  15. Hepatology. 1982 Sep-Oct;2(5):557-61 - PubMed
  16. Am J Pathol. 1986 May;123(2):264-70 - PubMed
  17. J Histochem Cytochem. 1984 Feb;32(2):219-29 - PubMed
  18. Hepatology. 1991 Jun;13(6):1029-34 - PubMed
  19. J Hepatol. 1991 May;12(3):382-5 - PubMed
  20. Proc Natl Acad Sci U S A. 1988 Feb;85(3):723-7 - PubMed
  21. J Mol Biol. 1982 Nov 25;162(1):43-67 - PubMed
  22. Hepatology. 1988 May-Jun;8(3):712-7 - PubMed
  23. Hepatology. 1988 May-Jun;8(3):449-54 - PubMed
  24. Hepatology. 1986 Jan-Feb;6(1):20-3 - PubMed
  25. J Virol Methods. 1985 Dec;12(3-4):251-62 - PubMed
  26. Nature. 1984 Dec 13-19;312(5995):639-41 - PubMed
  27. Cell Immunol. 1984 Apr 15;85(1):191-200 - PubMed
  28. Lab Invest. 1985 Jun;52(6):572-90 - PubMed
  29. Microb Pathog. 1989 May;6(5):311-25 - PubMed
  30. J Biol Chem. 1982 Nov 25;257(22):13169-72 - PubMed
  31. Hepatology. 1986 Sep-Oct;6(5):962-5 - PubMed
  32. Hepatology. 1991 Dec;14(6):975-9 - PubMed

Substances

MeSH terms

Publication Types